paints a grim picture of TransMedics' business practices. The report's allegations center on the company's warm perfusion technology platform, known as the Organ Care System (OCS), and its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

NCC AB Series B rounded out the top three leaders on Wednesday, with shares gaining 6.2%. Xvivo Perfusion AB posted the largest decline, dropping 7.2%, followed by Oersted A/S shares, which ...

Research reports are not currently available for 0RKL.L.

At close: 23 January at 9:30:07 am GMT-5 ...

We've identified the following companies as similar to Xvivo Perfusion AB (publ) because they operate in a related industry or sector. We also considered size, growth, and various financial ...

HB Wealth Management LLC lifted its holdings in shares of TransMedics Group ... The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that ...